Description and Brand Names
Información sobre medicamentos proporcionada por: IBM Micromedex
US Brand Name
Pemetrexed injection is used in combination with pembrolizumab and platinum cancer medicines to treat metastatic (cancer that has spread) non-squamous non-small cell lung cancer (NSCLC) with no EGFR or ALK gene mutations. It is also used together with cisplatin to treat advanced or metastatic, non-squamous NSCLC.
Pemetrexed injection is also used as maintenance treatment of advanced or metastatic NSCLC that has not progressed after a previous 4-cycle treatment with platinum cancer medicines. It is also used to treat metastatic non-squamous NSCLC that has come back after a previous chemotherapy.
Pemetrexed injection is also used together with cisplatin to treat malignant pleural mesothelioma (cancer that affects the inside lining of the lungs and chest wall) that cannot be removed by surgery. Pemetrexed belongs to the group of medicines called antineoplastics.
This medicine is given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms: